Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Simvastatin in Critically Ill Patients with Covid-19
the REMAP-CAP Investigators
Section of Clinical and Translational Research
Institute of Clinical and Translational Sciences (ICTS)
COVID-19 Researchers
Research output
:
Contribution to journal
›
Article
›
peer-review
15
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Simvastatin in Critically Ill Patients with Covid-19'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adaptive Design
12%
Adaptive Platform
12%
Adjusted Odds Ratio
12%
Bayesian Hierarchical Model
12%
COVID-19
100%
Creatine Kinase
12%
Credible Interval
25%
Critically Ill Patients
100%
Hazard Ratio
12%
In-hospital Death
12%
Liver Enzymes
12%
Odds Ratio
25%
Ordinal Models
12%
Ordinal Scale
12%
Organ Support
37%
Posterior Probability
50%
Probability of Superiority
25%
Randomized Controlled Trial
12%
Serious Adverse Events
12%
Simvastatin
100%
Statins
25%
Stopping Criterion
25%
Support-free
25%
Survivors
12%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
12%
Coronavirinae
100%
Creatine Kinase
12%
Disease
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
12%
Liver Enzyme
12%
Randomized Controlled Trial
12%
Simvastatin
100%
Statin (Protein)
12%
Nursing and Health Professions
Adverse Event
12%
Creatine Kinase
12%
Disease
100%
Hazard Ratio
12%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
12%
Liver Enzyme
12%
Odds Ratio
37%
Simvastatin
100%
Statin (Protein)
12%
Agricultural and Biological Sciences
Cardiovascular System
20%
Coronavirinae
100%
Creatine Kinase
20%
Odds Ratio
60%